Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar 24;20(4):5260-75.
doi: 10.3390/molecules20045260.

Synthesis and biological properties of 5-(1H-1,2,3-triazol-4-yl)isoxazolidines: a new class of C-nucleosides

Affiliations

Synthesis and biological properties of 5-(1H-1,2,3-triazol-4-yl)isoxazolidines: a new class of C-nucleosides

Salvatore V Giofrè et al. Molecules. .

Abstract

A novel series of C-nucleosides, featuring the presence of a 1,2,3-triazole ring linked to an isoxazolidine system, has been designed as mimetics of the pyrimidine nucleobases. An antiproliferative effect was observed for compounds 17a and 17b: the growth inhibitory effect reaches the 50% in HepG2 and HT-29 cells and increases up to 56% in the SH-SY5Y cell line after 72 h of incubation at a 100 µM concentration.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Examples of C-Nucleosides.
Figure 2
Figure 2
Phosphonated N,O-nucleosides.
Figure 3
Figure 3
Examples of N,O-Nucleosides.
Scheme 1
Scheme 1
Synthesis of C-Vinyl triazoles 12ag.
Scheme 2
Scheme 2
Synthesis of isoxazolidinyl-triazoles 16ag and 17ag by 1,3-dipolar cycloaddition.
Figure 4
Figure 4
Compound 17a reduces cell proliferation and induce LDH release. HepG2, HT-29 and SH-SY5Y cells were exposed to increased concentration of 17a compound for 24, 48 and 72 h. (A) Proliferation rate assessed by BrdU assay. (B) Cytotoxic effect assessed in terms of LDH release after 24 h of exposure. Each value is the mean ± S.E.M. of three experiments performed eight times (BrdU) or in triplicate (LDH) and repeated three different times. * p < 0.05 vs. ctrl, ** p < 0.01 vs. ctrl, *** p < 0.001 vs. ctrl.
Figure 5
Figure 5
Compound 17b inhibit cell growth and determine LDH release. (A) Proliferation rate assessed by BrdU assay after 24–72 h of treatment. (B) Cytotoxic activities evaluated by the test of LDH after 24 h of incubation. Each value is the mean ± S.E.M. of three experiments performed in eight times (BrdU) or in triplicate (LDH) and repeated three different times. * p < 0.05 vs. ctrl, ** p < 0.01 vs. ctrl, *** p < 0.001 vs. ctrl.

Similar articles

Cited by

References

    1. De Clercq E. The history of antiretrovirals: Key discoveries over the past 25 years. Rev. Med. Virol. 2009;19:287–299. - PubMed
    1. De Clercq E. Antiviral Drug Strategies. Wiley-VCH; Weinheim, Germany: 2011.
    1. Parker W.B. Enzymology of Purine and Pyrimidine Antimetabolites Used in the Treatment of Cancer. Chem. Rev. 2009;109:2880–2893. doi: 10.1021/cr900028p. - DOI - PMC - PubMed
    1. Vanek V., Budesinsky M., Rinnova M., Rosenberg I. Prolinol-based nucleoside phosphonic acids: New isosteric conformationally flexible nucleotide analogues. Tetrahedron. 2009;65:862–876. doi: 10.1016/j.tet.2008.11.035. - DOI
    1. Ishitsuka H., Shimma N. Capecitabine Preclinical Studies: From Discovery to Translational Research. In: Herdewijn P., editor. Modified Nucleosides in Biochemistry, Biotechnology and Medicine. Wiley-VCH; Weinheim, Germany: 2008. pp. 587–600.

Publication types

LinkOut - more resources